Prediction of tumour hypoxia and radioresistance with nuclear medicine markers

British Journal of Cancer

Volumn 74, Issue SUPPL. XXVII, 1996, Pages

  Chapman, J D ^a   Coia, L R ^a   Stobbe, C C ^a   Engelhardt, E L ^a   Fenning, M C ^a   Schneider, R F ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

D iodoazomycin galactoside; D iodoazomycin xylopyranoside; Iodoazomycin arabinoside; Single photon emission computerised tomography

Indexed keywords

2 NITROIMIDAZOLE; ARABINOSIDE; GALACTOSIDE; NUCLEOSIDE; PYRANOSIDE; DIAGNOSTIC AGENT; IODOAZOMYCIN ARABINOSIDE; NITROIMIDAZOLE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ASSAY; CELL CULTURE; CELL METABOLISM; CELL SUSPENSION; CONFERENCE PAPER; HYPOXIA; ISOTOPE LABELING; KINETICS; MOUSE; NONHUMAN; NUCLEAR MEDICINE; PLASMA CLEARANCE; PRIORITY JOURNAL; RADIOSENSITIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE OXYGENATION; TUMOR VOLUME; ANIMAL; ARTICLE; CELL HYPOXIA; EXPERIMENTAL NEOPLASM; METABOLISM; MOUSE MUTANT; RADIATION DOSE; RAT;

ANIMALS; CELL HYPOXIA; MICE; MICE, SCID; NEOPLASMS, EXPERIMENTAL; NITROIMIDAZOLES; RADIATION TOLERANCE; RATS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0029948844     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (21)

1. CHAPMAN JD. (1979). Hypoxic sensitizers: implications for radiation therapy. N. Engl. J. Med., 301, 1429-1432.
2. CHAPMAN JD. (1991). Measurement of tumor hypoxia by invasive and non-invasive procedures: a review of recent clinical studies. Radiother. Oncol., 20, 13-19.
3. CHAPMAN JD, FRANKO AJ AND SHARPLIN J. (1981). A marker for hypoxic cells in tumors with potential clinical applicability. Br. J. Cancer, 43, 546-550.
4. CHAPMAN JD, BAER K AND LEE J. (1983). Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res., 43, 1523-1528.
5. CHAPMAN JD, URTASUN RC, FRANKO AJ, RALEIGH JA, MEEKER BE AND MCKINNON SA. (1989). The measurement of oxygenation status of individual tumors. In Prediction of Response in Radiation Therapy: the Physical and Biological Basis, Fowler JF, Herbert DE, Kinsella TJ and Orton CG (eds). pp.49-60. American Institute of Physics: New York.
6. CHAPMAN JD, LEE J AND MEEKER BE. (1990). Adduct formation by 2-nitroimidazole drugs in mammalian cells: optimization of markers for tissue oxygenation. In Selective Activation of Drugs by Redox Processes, Adams GE, Breccia A, Fielden EM and Warden P. (eds). pp. 313-323. Plenum Press: New York.
7. CHAPMAN JD, STOBBE CC, ARNFIELD MR, SANTUS R, LEE J AND MCPHEE MS. (1991). Oxygen dependency of tumor cell killing in vitro by light-activated Photfrin II. Radiat. Res., 126, 73-79.
8. GRAY LH, CONGER AD, EBERT M, HORNSEY S AND SCOTT OCA. (1953). Concentration of oxygen dissolved in tissues at time of irradiation as a factor in radiotherapy. Br. J. Radiol., 26, 638-648.
9. GROSHAR D, MCEWAN AJB, PARLIAMENT MB, URTASUN RC, GOLDBERG LE, HOSKINSON M, MERCER JR, MANNAN RH, WEIBE LI AND CHAPMAN JD. (1993). Imaging tumor hypoxia and tumor perfusion. J. Nucl. Med., 34, 885-888.
10. 2 predicts survival in advanced cancer of the uterine cervix. Radiother. Oncol., 26, 45-50.
11. KOH WJ, RASEY JS, EVANS ML, GRIERSON JR, LEWELLEN TK, GRAHAM MM, KROHN KA AND GRIFFIN TW. (1992). Imaging of hypoxia in human tumors with [F-18] fluoromisonidazole. Int. J. Radiat. Oncol. Biol. Phys., 22, 199-212.
12. MANNAN RH, SOMAYAJI VV, LEE J, MERCER JR AND CHAPMAN JD. (1991). Radioiodinated 1-(5-Iodo-5-deoxy-D-arabinofuranoxyl)-2-nitroimidazole (Iodoazomycin Arabinoside: IAZA), a novel marker of tissue hypoxia. J. Nucl. Med., 32, 1764-1770.
13. MERCER JR, MANNAN RH, SOMAYAJI VV, LEE J, CHAPMAN JD AND WIEBE LI. (1990). Sugar-coupled 2-nitroimidazoles: Novel in vivo markers for hypoxic tumor tissue. In Advances in Radiopharmacology, Maddalena DJ, Snowdon GM and Boniface GR. (eds) p. 103-104. Int. Assoc. Radiopharmacol., Univ. Wollongong Printing Services: Wollongong, Australia.
14. 123I-Iodoazomycin arabinoside: Preliminary report of a clinical study. Br. J. Cancer, 65, 90-95.
15. STONE HB, BROWN JM, PHILLIPS TL AND SUTHERLAND RM. (1993). Oxygen in human tumors: Correlation between methods of measurement and response to therapy. Radiat. Res., 136, 422-434.
16. 2 at the cellular level. Br. J. Cancer, 54, 453-457.
17. URTASUN RC, PARLIAMENT MB, MCEWAN AJ, MERCER JR, MANNAN RH, WEIBE LI, MORIN C AND CHAPMAN JD. (1996). Measurement of hypoxia in human tumors by non-invasive SPECT imaging of iodoazomycin arabinoside. Br. J. Cancer, 73, (suppl. 27).
18. 2 tension measurements. Cancer Res., 51, 3316-3322.
19. VAUPEL P, SCHLENGER K AND HÖCKEL M. (1992). Blood flow and tissue oxygenation of human tumors: an update. In Oxygen Transport to Tissue XIV, Erdman W, Bruley DF. (eds) pp. 139-151. Plenum Press: New York.
20. WONG TW, WHITMORE GF AND GULYAS S. (1978). Studies on the toxicity and radiosensitizing ability of misonidazole under conditions of prolonged incubation. Radiat. Res., 75, 541-555.
21. YEH KA, BIADE S, LANCIANO RM, BROWN DQ, FENNING MC, BABB J, HANKS GE AND CHAPMAN JD. . (1995). Polarographic needle electrode measurements of oxygen in rat prostate carcinomas: accuracy and reproducibility. Int. J. Radiat. Oncol. Biol. Phys., 33, 111-118.